You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
We do not review or control the content on non-Medtronic sites, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations.
Click “OK” to confirm you are a Healthcare Professional.
Find links to third party education sites and view recorded
sessions from global RDN experts on the latest clinical data,
patient selection criteria and RDN procedure updates.
Medscape’s education platform helps physicians learn about recent data with innovative interventional technology that can help patients achieve blood pressure control as an alternative to, or in addition to, typical treatment plans that include anti-hypertensive medications and lifestyle modifcations. CME credits available.
Radcliffe offers CME courses and webinars exploring renal denervation, clinical data, and many other topics, featuring Prof. Stefano Taddei, Prof. Atul Pathak, Prof. Andrew Sharp, Prof. Roland Schmeider, and other distinguished faculty. CME credits available.
WONDR Medical regularly introduces training resources and a wide array of video content in multiple languages at RDN:NOW.
The American Heart Association (AHA) offers a hypertension professional education series with new learning modules added regularly. Content includes webinars, spotlight series and podcasts. CME credits available.
This American College of Cardiology (ACC) education initiative platform helps learners evaluate and select evidence-based interventions and contemporary approaches for the treatment and control of hypertension. CME credits available.
Content includes webinars, podcasts, certifed cases, quick tip videos, gamifcation, patient case quizzes, and interactive cases/lessons.
See which types of patients could beneft from the Symplicity blood pressure procedure.
The Symplicity blood pressure procedure is supported by multiple clinical trials and a real-world patient registry.1-4
The Symplicity blood pressure procedure is changing how patients with hypertension can reduce their blood pressure.
Mahfoud F, Kandzari DE, Kario K, et al. Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial. The Lancet. 2022;399:1401-1410.
Mahfoud F, Mancia G, Schmieder R, et al. Three-year safety and efficacy in the Global Symplicity Registry: Impact of antihypertensive medication burden on blood pressure reduction. Presented at PCR e-course 2020.
Böhm M, Kario K, Kandzari DE, et al. Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial. The Lancet. 2020;395:1444-1451.
Kandzari DE, Böhm M, Mahfoud F, et al. Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial. The Lancet. 2018;391(10137):2346.